HRASLS3 is a PPARγ-selective target gene that promotes adipocyte differentiation

Journal of Lipid Research

Volumn 49, Issue 12, 2008, Pages 2535-2544

  Hummasti, Sarah ^a   Hong, Cynthia ^a   Bensinger, Steven J ^a   Tontonoz, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adipogenesis; Lipid metabolism; Nuclear receptor

Indexed keywords

GENE PRODUCT; HRAS LIKE SUPRESSOR 3 PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; HRASLS3 PROTEIN, MOUSE; PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC REGULATION; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; WHITE ADIPOSE TISSUE; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; MICE; NIH 3T3 CELLS; PPAR GAMMA; PROTEINS; TRANSFECTION;

EID: 59649086282     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800269-JLR200     Document Type: Article

References (40)

1. Spiegelman, B. M., and J. S. Flier. 2001. Obesity and the regulation of energy balance. Cell. 104: 531-543.
2. Staiger, H., and H. U. Haring. 2005. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp. Clin. Endocrinol. Diabetes. 113: 67-79.
3. Flegal, K. M., M. D. Carroll, C. L. Ogden, and C. L. Johnson. 2002. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 288: 1723-1727.
4. Prestwich, T. C., and O. A. Macdougald. 2007. Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr. Opin. Cell Biol. 19: 612-617.
5. Rosen, E. D., O. A. MacDougald. 2006. Adipocyte differentiation from the inside out. Nature Reviews. 7: 885-896.
6. Rosen, E. D., and B. M. Spiegelman. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16: 145-171.
7. MacDougald, O. A., and M. D. Lane. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64: 345-373.
8. Hu, E., P. Tontonoz, and B. M. Spiegelman. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. USA. 92: 9856-9860.
9. Mueller, E., S. Drori, A. Aiyer, J. Yie, P. Sarraf, H. Chen, S. Hauser, E. D. Rosen, K. Ge, R. G. Roeder, et al. 2002. Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J. Biol. Chem. 277: 41925-41930.
10. Ren, D., T. N. Collingwood, E. J. Rebar, A. P. Wolffe, and H. S. Camp. 2002. PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev. 16: 27-32.
11. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 79: 1147-1156.
12. Zhang, J., M. Fu, T. Cui, C. Xiong, K. Xu, W. Zhong, Y. Xiao, D. Floyd, J. Liang, E. Li, et al. 2004. Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. Proc. Natl. Acad. Sci. USA. 101: 10703-10708.
13. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83: 803-812.
14. Nolte, R. T., G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, and M. V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 395: 137-143.
15. Xu, H. E., M. H. Lambert, V. G. Montana, D. J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, et al. 1999. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell. 3: 397-403.
16. Evans, R. M., G. D. Barish, and Y. X. Wang. 2004. PPARs and the complex journey to obesity. Nat. Med. 10: 355-361.
17. Lehrke, M., and M. A. Lazar. 2005. The many faces of PPARgamma. Cell. 123: 993-999.
18. Arimura, N., T. Horiba, M. Imagawa, M. Shimizu, and R. Sato. 2004. The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J. Biol. Chem. 279: 10070-10076.
19. Auwerx, J., K. Schoonjans, J. C. Fruchart, and B. Staels. 1996. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis. 124 (Suppl): S29-S37.
20. Schoonjans, K., J. Peinado-Onsurbe, A. M. Lefebvre, R. A. Heyman, M. Briggs, S. Deeb, B. Staels, and J. Auwerx. 1996. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15: 5336-5348.
21. Targett-Adams, P., M. J. McElwee, E. Ehrenborg, M. C. Gustafsson, C. N. Palmer, and J. McLauchlan. 2005. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim. Biophys. Acta. 1728: 95-104.
22. Havel, P. J. 2002. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13: 51-59.
23. Hodgkinson, C. P., and S. Ye. 2003. Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages. Biochem. Biophys. Res. Commun. 308: 505-510.
24. Hummasti, S., and P. Tontonoz. 2006. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Mol. Endocrinol. 20: 1261-1275.
25. Perera, R. J., E. G. Marcusson, S. Koo, X. Kang, Y. Kim, N. White, and N. M. Dean. 2006. Identification of novel PPARgamma target genes in primary human adipocytes. Gene. 369: 90-99.
26. Brun, R. P., P. Tontonoz, B. M. Forman, R. Ellis, J. Chen, R. M. Evans, and B. M. Spiegelman. 1996. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev. 10: 974-984.
27. Ramirez-Carrozzi, V. R., A. A. Nazarian, C. C. Li, S. L. Gore, R. Sridharan, A. N. Imbalzano, and S. T. Smale. 2006. Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes Dev. 20: 282-296.
28. Brummelkamp, T. R., R. Bernards, R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296: 550-553.
29. Bradley, M. N., C. Hong, M. Chen, S. B. Joseph, D. C. Wilpitz, X. Wang, A. J. Lusis, A. Collins, W. A. Hseuh, J. L. Collins, et al. 2007. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J. Clin. Invest. 117: 2337-2346.
30. Castrillo, A., S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278: 10443-10449.
31. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91: 7355-7359.
32. Laffitte, B. A., J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, and P. Tontonoz. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA. 98: 507-512.
33. Sers, C., U. Emmenegger, K. Husmann, K. Bucher, A. C. Andres, and R. Schafer. 1997. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J. Cell Biol. 136: 935-944.
34. Font de Mora, J., A. Porras, N. Ahn, and E. Santos. 1997. Mitogenactivated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol. Cell. Biol. 17: 6068-6075.
35. Hajnal, A., R. Klemenz, and R. Schafer. 1994. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Oncogene. 9: 479-490.
36. Houseknecht, K. L., A. X. Zhu, L. Gnudi, A. Hamann, J. R. Zierath, E. Tozzo, J. S. Flier, and B. B. Kahn. 1996. Overexpression of Ha-ras selectively in adipose tissue of transgenic mice. Evidence for enhanced sensitivity to insulin. J. Biol. Chem. 271: 11347-11355.
37. Miyaoka, Y., M. Tanaka, T. Naiki, and A. Miyajima. 2006. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J. Biol. Chem. 281: 37913-37920.
38. Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307.
39. Rosen, E. D. 2005. The transcriptional basis of adipocyte development. Prostaglandins Leukot. Essent. Fatty Acids. 73: 31-34.
40. Gelman, L., J. C. Fruchart, and J. Auwerx. 1999. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell. Mol. Life Sci. 55: 932-943.